Thread: Another double-blind, clinical study of Nilotinib for Parkinson's
View Single Post
Old 10-06-2016, 10:41 AM
zanpar321 zanpar321 is offline
Member
  
Join Date: Feb 2014
Posts: 365
10 yr Member
zanpar321 zanpar321 is offline
Member
 
Join Date: Feb 2014
Posts: 365
10 yr Member
Default Another double-blind, clinical study of Nilotinib for Parkinson's
This is really heating up!

According to an Inhibikase Therapeutics media release, the Investigational New Drug (IND) application filed by the company has received FDA clearance to initiate this clinical trial and should begin patient evaluation for enrollment within a few months.

A double-blind, placebo-controlled clinical study of Nilotinib (Tasigna(R)) in patients with Parkinson's disease - AdisInsight
zanpar321 is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
anagirl (10-06-2016), lab rat (10-12-2016), Lana (10-06-2016), olsen (10-06-2016), Tupelo3 (10-06-2016)